Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 0 | 0 | 0 | 1,300 |
| Gross Profit | N/A | N/A | N/A | N/A | 1,300 |
| Operating Expenses | 32,149 | 30,927 | 30,923 | 33,812 | 28,689 |
| Operating Income | -32,149 | -30,927 | -30,923 | -33,812 | -27,389 |
| Interest Expense | 5,693 | 3,509 | 3,185 | 3,181 | 3,141 |
| Other Income | 1,195 | 995 | 1,274 | 1,737 | 1,878 |
| Pre-tax Income | -36,647 | -33,441 | -32,834 | -35,256 | -28,652 |
| Income Tax | 3 | N/A | N/A | N/A | 2 |
| Net Income Continuous | -36,650 | -33,441 | -32,834 | -35,256 | -28,654 |
| Net Income | $-36,650 | $-33,441 | $-32,834 | $-35,256 | $-28,654 |
| EPS Basic Total Ops | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 |
| EPS Basic Continuous Ops | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 |
| EPS Diluted Total Ops | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 |
| EPS Diluted Continuous Ops | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.15 | -2.11 | -2.28 | -1.85 |
| EBITDA(a) | $-31,626 | $-30,390 | $-30,359 | $-33,229 | $-26,728 |